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Abstract: About 85-90% of all ovarian cancers are carcinomas; these manifest clinically as
mass-forming epithelial proliferations involving the ovary. In this study, a visible light spatial
frequency domain imaging (SFDI) system was used for multispectral ex vivo imaging and
quantitative evaluation of freshly excised benign and malignant human ovarian tissues. A
total of 14 ovaries from 11 patients undergoing oophorectomy were investigated. Using a
logistic regression model with seven significant spectral and spatial features extracted from
SFDI images, a sensitivity of 94.06% and specificity of 93.53% were achieved for prediction
of histologically confirmed invasive carcinoma.
© 2018 Optical Society of America under the terms of the OSA Open Access Publishing Agreement
OCIS codes: (170.0170) Medical optics and biotechnology; (170.4440) ObGyn; (170.6935) Tissue characterization.
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1. Introduction
Cancer of the ovary remains the deadliest of all the gynecological malignancies, accounting
for over 14,000 deaths annually in the US. Due to the lack of reliable early symptoms and
efficacious screening techniques, most of ovarian cancers are diagnosed at late stages (III and
IV) [1]. Optical imaging modalities such as optical coherence tomography (OCT),
photoacoustic imaging (PAI), have been used separately or in combination for high-resolution
imaging of benign and malignant ovarian tissue microstructures [2–4]. These studies have
established that absorption parameters are important biomarkers related to tumor angiogenesis
and tumor metabolism, whereas, changes in the scattering properties have been found to be
associated with neoplastic alterations in the ovarian collagen structure as well as tumor
necrosis. Some of the limitations of these techniques include limited field of view (FOV),
reduced depth sampling due to multiple scattering and discrete sampling for wide field
implementation. Spatial frequency domain imaging (SFDI) is an emerging planar imaging
modality that can separate optical absorption and scattering to provide large-field, depth
sampled quantitative evaluation of biological tissue [5–8]. The majority (85-90%) of ovarian
malignancies are epithelial cancers, many of which likely arise from Fallopian tube
epithelium, and are thought to spread early to the ovary, where they then manifest clinically
as expanding masses in the ovarian cortex. Previously, a single wavelength SFDI system with
a bulky projection unit was used to image differences in absorption, scattering as well as
spatial heterogeneities between benign and malignant ovarian tissues [9]. In the current study,
we have used a multispectral SFDI system with a miniaturized projector at visible
wavelengths for ex vivo quantification of wavelength dependent chromophores as well as
spatial heterogeneities of freshly excised benign and malignant ovarian tissues. Using a
logistic regression classifier, the sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV), as well as the area under the receiver operator characteristic
(ROC) curve (AUC) were evaluated.
2. Materials and methods
2.1 Human ovary samples
Freshly excised ovarian tissues were collected from patients undergoing oophorectomy for
suspected risk of ovarian cancer, or having an ovarian/pelvic mass suggestive of malignancy,
at Washington University School of Medicine. The study was approved by the Institutional
Review Board (IRB) at Washington University. Informed consent was obtained from all
patients. Care was taken during the surgery to remove the ovaries intact. All imaging was
completed within 1 hour of surgery. After imaging, the tissues were returned to the pathology
department for histological processing.
2.2 SFDI system
Figure 1 shows the configuration of the free space SFDI system. Sinusoidal patterns
generated in MATLAB were projected from a miniaturized Pico projector (RIF6 cube,
dimension 2”x2”x1.9”, brightness 50 lumens), and the diffuse reflected light was recorded by
a 12 bit CCD camera (Basler ace, 30 fps, dynamic range 57 dB) and bandpass filters
(Thorlabs, bandwidth ± 10 nm). Three wavelengths (460 nm, 530 nm and 630 nm) and two
optimized spatial frequencies (0 and 1 cm−1) were used for this study. The specular reflection
was minimized by two crossed linear polarizers. The field of view (FOV) captured by the
camera was 4 cm x 4 cm.
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Fig. 1. SFDI system configuration.

For each wavelength, three phase shifted images (0, 120 and 240 degrees) were recorded,
and the DC and AC components of the amplitude were calculated. A Monte Carlo simulationbased two-frequency lookup table was used for calculating the wide-field tissue absorption
and reduced scattering maps. The system was calibrated with a known intralipid
concentration (0.08%) and solid-tissue–mimicking phantoms, and both the absorption and
scattering errors were within 5%. A calibration based profilometry correction was applied to
account for sample surface variation [10]. The height mismatch between the reference
phantom and sample was carefully adjusted to be less than 1 mm, which had negligible
scaling effect on the measured diffuse reflectance.
2.3 Extraction of spectral and spatial features
Depending on the size of the ovarian mass (1.1 cm-9.5 cm), several nonoverlapping images
were recorded for each sample, and subsequently each SFDI absorption and scattering image
was subdivided into independent regions of interest of same size (1 cm x 1 cm, 200 x 200
pixels) for extracting the spectral and spatial features. Four features were quantitatively
extracted from the observed differences between the wavelength-dependent absorption and
scattering properties. These were the total hemoglobin (HbT), oxygen saturation (sO2),
scatter amplitude and scatter spectral slope. HbT and sO2 are important prognosticators of
angiogenesis and oxygen consumption, respectively, which are related to tumor progression.
The scatter amplitude was proportional to the concentration of elastic scatterers, mainly
collagen in the ovarian stroma, as established by previous studies [11]. The scatter spectral
slope was related to the size of the scatterers, with higher slope indicating the presence of
smaller collagen fibrils that enhanced Rayleigh-type scattering [8, 12]. Four additional
features related to the heterogeneity of absorption and scattering were calculated from the
SFDI images. This has been described in detail in Ref. 9. For calculating the spatial features,
only a single wavelength (530 nm) was used, because the spatial features obtained from other
two wavelengths were correlated and did not add more independent information.
2.4 Feature selection and classification
A two-step approach was used for classification of the different ovarian tissue types. In the
first step, the features were ranked in order of decreasing p values obtained from Student’s t
test, and one feature with p > 0.05 was excluded from the classification. Next, a logistic
regression model was trained using the MATLAB GLMFIT function with the seven
significant features as predictor variables and the pathological diagnosis (1 for malignant, 0
for normal/benign) as response variables. The model was tested using GLMVAL function for
estimating the response of the testing set. The receiver operating curve (ROC) and the area
under the curve (AUC) were used for evaluating the accuracy of the model.
3. Results and discussions
After excluding one collapsed cystic ovary from one patient, and another two ovaries from
another patient with ink on the ovary surface, we imaged a total of 14 intact ovaries (10
normal/benign, 4 malignant) from 11 patients using the SFDI system. The non-cancerous
samples consisted of normal (n = 2) and enlarged but benign ovaries (n = 8). The diagnoses
for the benign ovarian masses consisted of cystic ovaries and fibrothecoma. The malignant
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samples consisted of a borderline serous tumor (n = 1), two endometroid adenocarcinomas (n
= 2) and a high-grade serous carcinoma (n = 1). Most of the benign ovaries (9 ovaries) were
from post-menopausal patients, while all the malignant ovaries were from pre-menopausal
patients. The borderline tumor was included in the malignant category due to the clinical
impact of this diagnosis.

Fig. 2. Color photograph, absorption, reduced scattering (530 nm), total hemoglobin map,
H&E image from representative areas of a benign fibrothecoma (a-e) and a high-grade serous
carcinoma (f-j); Black dashed area showing the ROI for feature selection.

Figure 2 shows the color photograph, absorption, and reduced scattering maps at 530 nm,
total hemoglobin (HbT) as well as representative H&E-stained histology images from
corresponding areas of a benign ovarian fibrothecoma (2a-2e) and a high-grade serous
carcinoma (2f-2j) respectively. A fibrothecoma was chosen for comparison here because it
represents a mass-forming process, potentially mimicking a malignancy, yet is benign. Six
fallopian tubes (all normal) were also imaged; however, due to lack of any malignant
fallopian tubes in the current sample pool, fallopian tubes were not included for classification
in this study.
It was observed that the malignant ovaries had significantly higher total hemoglobin as
well as lower scatter amplitude and slope, as shown in Fig. 3. This may be due to increased
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angiogenesis and lack of elastic scatterers such as stromal collagen in the malignant ovarian
tissue compared to the non-cancerous ovaries, as evident in the H&E images from the
imaging areas of benign and malignant ovaries in Fig. 2(e) and 2(j). Additionally, the
absorption and scatter heterogeneity was also highest for the malignant group, signifying
clustered, random distribution of micro vessels as well as scattered collagen distribution. The
SD of the Gaussian fitting function was also found to be significantly lower for the malignant
group as compared to the normal group. In terms of statistical significance, HbT was found to
be the most important feature, followed by scatter slope, scatter amplitude, absorption
heterogeneity, absorption SD, scatter heterogeneity and scatter SD. Oxygen saturation was
not found to be a significant ex vivo feature (p = 0.53), which might be due to variations after
resection, as reported by other researchers [13].

Fig. 3. Scatter plot of spectral features of Normal/Benign and Malignant ovaries.

A total of 53 independent ROIs (35 normal/benign, 18 cancer) were used for quantitative
feature extraction. Figure 4 (a-g) show the boxplots of the seven features calculated from the
spectral and spatial differences between the different types of ovarian tissue. Approximately
two thirds of the data (30 ROIs, including 20 normal/benign, 10 cancer) were used for
training and the rest were used for testing the logistic model. Figure 5 shows the ROC curves
and AUC of the training and testing set. For the training set, we obtained sensitivity 97.69%,
specificity 96.97%, PPV 96.21%, NPV 97.97% and AUC (95% confidence interval) of 0.985.
For the testing set, we obtained sensitivity 94.06%, specificity 93.53%, PPV 92.23%, NPV
95.04% and AUC (95% confidence interval) of 0.938.
The current work improves on our previous SFDI ovary study in terms of multispectral
information of important tissue chromophores, as well as reduction of overall size of the
projection unit. However, the limited sample size (n = 14) remains a challenge, as well as lack
of benign or malignant fallopian tubes in the current sample pool. This is of interest, as some
recent research has indicated the fallopian tube as the potential site of origin for ovarian
cancer [14]. Since the technology is best suited for assessing the surface of the ovary, it might
have limited ability to detect small foci of invasion (i.e., malignancy) occurring at depth
within a large ovarian mass. For translating this technology from bench to bedside, a fully
hand-held multispectral SFDI projection and camera based system is currently being
developed, which can be readily used by the surgeons in the operating room for quantitative
evaluation of the ovarian and fallopian tube tissue surface, and reduce the risk of unnecessary
surgeries.
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Fig. 4. Boxplots of (a) Total hemoglobin; (b) Scatter slope; (c) Scatter amplitude; (d)
Absorption Gaussian MSE; (e) Absorption. SD; (f) Scatter Gaussian MSE; (g) Scatter SD.

AUC = 0.985

AUC = 0.938

(a)

(b)

Fig. 5. ROC curves of (a) Training; (b) Testing.

4. Conclusions
In this study, a multispectral SFDI system was used for quantitative, wide-field evaluation of
human ovarian tissues. 14 ovaries from 11 patients were imaged and based on the spectral and
spatial differences in absorption and scattering properties of normal/benign and malignant
ovaries, seven features were extracted from the SFDI images. Using a logistic regression
model, sensitivity of 94.06%, specificity of 93.53%, PPV 92.23%, NPV 95.04% was
obtained. The initial promising results indicate the prospect of using SFDI for intraoperative
assessment of the ovarian tissue to avoid potentially unnecessary surgeries. Future studies
will be concentrated on upgrading this technology from bench to bedside and building SFDI
systems that can be readily used in the operating room.
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